199 related articles for article (PubMed ID: 31763044)
1. Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys.
Horita S; Watanabe M; Katagiri M; Nakamura H; Haniuda H; Nakazato T; Kagawa Y
Pharmacol Res Perspect; 2019 Dec; 7(6):e00545. PubMed ID: 31763044
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of pazopanib eye drops versus ranibizumab intravitreal injections in subjects with neovascular age-related macular degeneration.
Csaky KG; Dugel PU; Pierce AJ; Fries MA; Kelly DS; Danis RP; Wurzelmann JI; Xu CF; Hossain M; Trivedi T
Ophthalmology; 2015 Mar; 122(3):579-88. PubMed ID: 25432081
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of pazopanib eye drops in healthy subjects and in subjects with neovascular age-related macular degeneration.
Singh R; Wurzelmann JI; Ye L; Henderson L; Hossain M; Trivedi T; Kelly DS
Retina; 2014 Sep; 34(9):1787-95. PubMed ID: 24896137
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
Song JH; Moon KY; Lee SC; Kim SS
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
[TBL] [Abstract][Full Text] [Related]
6. [Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use].
Thiele S; Liegl RG; König S; Siedlecki J; Langer J; Eibl K; Haritoglou C; Kampik A; Kernt M
Klin Monbl Augenheilkd; 2013 Mar; 230(3):247-54. PubMed ID: 23508753
[TBL] [Abstract][Full Text] [Related]
7. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
8. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.
Stacchiotti S; Tortoreto M; Baldi GG; Grignani G; Toss A; Badalamenti G; Cominetti D; Morosi C; Dei Tos AP; Festinese F; Fumagalli E; Provenzano S; Gronchi A; Pennacchioli E; Negri T; Dagrada GP; Spagnuolo RD; Pilotti S; Casali PG; Zaffaroni N
Eur J Cancer; 2014 Nov; 50(17):3021-8. PubMed ID: 25269954
[TBL] [Abstract][Full Text] [Related]
9. A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration.
Huang WC; Cheng F; Chen CC; Kuo PH; Wang YJ; Yin SC; Tu CM; Wu MH; Wang WY; Chen SE
Transl Vis Sci Technol; 2021 Dec; 10(14):23. PubMed ID: 34932116
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Antineovascularization Activity and Ocular Pharmacokinetics of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GNE-947.
Liu X; Liang X; LeCouter J; Ubhayakar S; Chen J; Cheng J; Lee T; Lubach J; Nonomiya J; Shahidi-Latham S; Quiason C; Solon E; Wright M; Hop CECA; Heffron TP
Drug Metab Dispos; 2020 May; 48(5):408-419. PubMed ID: 32132091
[TBL] [Abstract][Full Text] [Related]
11. Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease.
Robbie SJ; Lundh von Leithner P; Ju M; Lange CA; King AG; Adamson P; Lee D; Sychterz C; Coffey P; Ng YS; Bainbridge JW; Shima DT
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1490-500. PubMed ID: 23385800
[TBL] [Abstract][Full Text] [Related]
12. A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs.
Tran J; Craven C; Wabner K; Schmit J; Matter B; Kompella U; Grossniklaus HE; Olsen TW
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3732-3740. PubMed ID: 28738417
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Efficacy of a Novel Acetylated Tetrapeptide in Animal Models of Age-Related Macular Degeneration.
Koo HC; Baek YY; Choi JS; Kim YM; Sung B; Kim MJ; Kim JG; You JC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918777
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein mutant eye drops for the treatment of posterior eye diseases.
Suda K; Murakami T; Gotoh N; Fukuda R; Hashida Y; Hashida M; Tsujikawa A; Yoshimura N
J Control Release; 2017 Nov; 266():301-309. PubMed ID: 28987881
[TBL] [Abstract][Full Text] [Related]
15. Topical Ophthalmic Liposomes Dual-Modified with Penetratin and Hyaluronic Acid for the Noninvasive Treatment of Neovascular Age-Related Macular Degeneration.
Sun C; Zhang S; Xu N; Liu K; Wei F; Zhang X; Zhang J; Gao S; Yu Y; Ding X
Int J Nanomedicine; 2024; 19():1887-1908. PubMed ID: 38414529
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
[TBL] [Abstract][Full Text] [Related]
17. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
[TBL] [Abstract][Full Text] [Related]
18. The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial.
Joussen AM; Wolf S; Kaiser PK; Boyer D; Schmelter T; Sandbrink R; Zeitz O; Deeg G; Richter A; Zimmermann T; Hoechel J; Buetehorn U; Schmitt W; Stemper B; Boettger MK
Br J Clin Pharmacol; 2019 Feb; 85(2):347-355. PubMed ID: 30341774
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.
Zahn G; Vossmeyer D; Stragies R; Wills M; Wong CG; Löffler KU; Adamis AP; Knolle J
Arch Ophthalmol; 2009 Oct; 127(10):1329-35. PubMed ID: 19822850
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
